SCHEMBL8619950

SCHEMBL8619950

CC(=CCCCO)CCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
TRPV1 Q8NER1 2/20 0.47
TDP1 Q9NUW8 1/20 0.45
LSS P48449 2/20 0.45
KEAP1 Q14145 1/20 0.41
SIGMAR1 Q99720 2/20 0.41
SQLE Q14534 3/20 0.41
GPR52 Q9Y2T5 1/20 0.40
LTA4H P09960 1/20 0.39
EPHX2 P34913 1/20 0.39
HDAC3 O15379 1/20 0.39
MAPK1 P28482 1/20 0.39
ADRA1A P35348 1/20 0.39
HDAC4 P56524 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HDAC1 Q13547 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8619944 1.00 ALDH1A1 (0.47) ALDH1A1TRPV1TDP1LSSKEAP1
SCHEMBL8624953 0.90 LSS (0.49) ALDH1A1TRPV1TDP1LSSSQLE
SCHEMBL8624956 0.90 LSS (0.49) ALDH1A1TRPV1TDP1LSSSQLE
SCHEMBL29105881 0.85 ALDH1A1 (0.53) ALDH1A1TRPV1TDP1LSSKEAP1
SCHEMBL8626255 0.85 TRPV1 (0.46) ALDH1A1TRPV1LSSKEAP1SIGMAR1
SCHEMBL8626252 0.85 TRPV1 (0.46) ALDH1A1TRPV1LSSKEAP1SIGMAR1
SCHEMBL28415205 0.83 TRPV1 (0.54) ALDH1A1TRPV1TDP1LSSKEAP1
SCHEMBL21486330 0.82 ALDH1A1 (0.53) ALDH1A1TRPV1TDP1LSSKEAP1
SCHEMBL29572084 0.82 ALDH1A1 (0.53) ALDH1A1TRPV1TDP1LSSKEAP1
SCHEMBL26090626 0.81 ALDH1A1 (0.48) ALDH1A1TRPV1TDP1LSSKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed
EP-0595635-A1 Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors E.R. Squibb & Sons, Inc. (US) 1994-05-04 EP disclosed